Patrick Ott MD, PhD

Patrick Ott, MD, PhD, received his MD and PhD from Ludwig Maximilians University of Munich, Germany. He completed post-doctoral training in Immunology and residency training in Medicine at Case Western Reserve University. After a fellowship in Hematology-Oncology and four years on the faculty at New York University, he moved to Dana Farber Cancer Institute (DFCI)in 2012. He is currently the Clinical Director of both the Melanoma Center and the Center for Immuno-Oncology at DFCI, serves as attending physician in the Department of Medicine at Brigham and Women’s Hospital, and has an appointment as Assistant Professor at Harvard Medical School in Boston, MA. Dr Ott is a clinical investigator and an integral member of the clinical trials program at Dana Farber/Harvard Cancer Center, where he designs and conducts phase 1 immunotherapy trials for patients with melanoma and a wide range of other tumors. His primary research interests are in melanoma and immunotherapy, specifically the development of innovative tumor vaccine approaches.